Isolated abducens nerve palsy induced by vincristine therapy

J AAPOS. 2004 Feb;8(1):69-71. doi: 10.1016/S1091853103003239.

Abstract

We report a 28-year-old man with non-Hodgkin's lymphoma who presented with acute onset of diplopia 3 weeks after the completion of combination chemotherapy with vincristine. He had a left esotropia with marked decrease in abduction. Magnetic resonance imaging scan of the brain showed thickening and enhancement of the left abducens nerve. Lymphomatous and other intracranial pathologies were excluded, and vincristine neurotoxicity was considered as the possible etiology of the abducens nerve palsy. His diplopia improved gradually, then completely resolved 4 weeks after the cessation of vincristine therapy. We concluded that isolated ocular muscle paresis can be the presenting sing of a toxic neuropathy associated with vincristine use.

Publication types

  • Case Reports

MeSH terms

  • Abducens Nerve / drug effects
  • Abducens Nerve Diseases / chemically induced*
  • Abducens Nerve Diseases / diagnosis
  • Abducens Nerve Diseases / therapy
  • Adult
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Diplopia / chemically induced
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Treatment Outcome
  • Vincristine / adverse effects*
  • Visual Acuity

Substances

  • Antineoplastic Agents, Phytogenic
  • Vincristine